Structural and functional specificity of H3K36 methylation
The methylation of histone H3 at lysine 36 (H3K36me) is essential for maintaining genomic
stability. Indeed, this methylation mark is essential for proper transcription, recombination …
stability. Indeed, this methylation mark is essential for proper transcription, recombination …
The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors
Abstract NSD1, NSD2, and NSD3 constitute the nuclear receptor-binding SET Domain
(NSD) family of histone 3 lysine 36 (H3K36) methyltransferases. These structurally similar …
(NSD) family of histone 3 lysine 36 (H3K36) methyltransferases. These structurally similar …
The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate
Y Li, P Trojer, CF Xu, P Cheung, A Kuo… - Journal of Biological …, 2009 - ASBMB
The NSD (nuclear receptor SET domain-containing) family of histone lysine
methyltransferases is a critical participant in chromatin integrity as evidenced by the number …
methyltransferases is a critical participant in chromatin integrity as evidenced by the number …
The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation
Q Qiao, Y Li, Z Chen, M Wang, D Reinberg… - Journal of Biological …, 2011 - ASBMB
The Sotos syndrome gene product, NSD1, is a SET domain histone methyltransferase that
primarily dimethylates nucleosomal histone H3 lysine 36 (H3K36). To date, the intrinsic …
primarily dimethylates nucleosomal histone H3 lysine 36 (H3K36). To date, the intrinsic …
The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors
HR Hudlebusch, E Santoni-Rugiu, R Simon… - Clinical cancer …, 2011 - AACR
Abstract Purpose: Multiple myeloma SET (Suppressor of variegation, Enhancer of zeste, and
Trithorax) domain (MMSET) is a histone lysine methyltransferase deregulated in a subgroup …
Trithorax) domain (MMSET) is a histone lysine methyltransferase deregulated in a subgroup …
NSD2 is a conserved driver of metastatic prostate cancer progression
Deciphering cell-intrinsic mechanisms of metastasis progression in vivo is essential to
identify novel therapeutic approaches. Here we elucidate cell-intrinsic drivers of metastatic …
identify novel therapeutic approaches. Here we elucidate cell-intrinsic drivers of metastatic …
[HTML][HTML] The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy
Y Yang, M Zhang, Y Wang - Journal of the National Cancer Center, 2022 - Elsevier
Histone modifications are key factors in chromatin packaging, and are responsible for gene
regulation during cell fate determination and development. Abnormal alterations in histone …
regulation during cell fate determination and development. Abnormal alterations in histone …
Identification of histone methyltransferase NSD2 as an important oncogenic gene in colorectal cancer
L Zhao, Q Li, ZJ Huang, MX Sun, J Lu, X Zhang… - Cell Death & …, 2021 - nature.com
Colorectal cancer (CRC) is the second common cause of cancer-related human mortalities.
Dysregulation of histone 3 (H3) methylation could lead to transcriptional activation of …
Dysregulation of histone 3 (H3) methylation could lead to transcriptional activation of …
The lncRNA SLNCR recruits the androgen receptor to EGR1-bound genes in melanoma and inhibits expression of tumor suppressor p21
Melanoma is the deadliest form of skin cancer, affecting men more frequently and severely
than women. Although recent studies suggest that differences in activity of the androgen …
than women. Although recent studies suggest that differences in activity of the androgen …
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis
Androgen receptor (AR) is a ligand-responsive transcription factor that drives terminal
differentiation of the prostatic luminal epithelia. By contrast, in tumors originating from these …
differentiation of the prostatic luminal epithelia. By contrast, in tumors originating from these …